The Effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a Potent Agonist at Kappa- and Mu-opiate Receptors, on Urine Excretion of Rats
Overview
Affiliations
The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride (M320) on urine excretion by rats were investigated. Further studies, using rabbit isolated vas deferens, investigated its interactions with kappa-opiate receptors. The output of urine for a 2 h period after M320, administered subcutaneously to normally hydrated Long Evans rats, showed a bell-shaped dose-response relationship, the maximum effect occurring after 10 micrograms kg-1. Urinary retention contributed to but did not fully account for the weaker diuresis after high doses. Attenuation of the ascending portion of the dose-response curve to M320 occurred after 1 and 10 mg kg-1 but not 0.1 mg kg-1 of naltrexone intraperitoneally. M320 in low doses (3-10 micrograms kg-1) caused a small but significant increase in sodium excretion. M320 (30 micrograms kg-1) reduced both sodium and potassium excretion. M320 (10 micrograms kg-1 s.c.) did not increase the volume of urine voided in 2 h by Brattleboro rats showing diabetes insipidus, even when urine excretion was reduced to normal by 1 week of vasopressin replacement. The volume of urine voided in 4 h by Brattleboro rats was progressively reduced to zero by M320 (10-100 micrograms kg-1 s.c.). Urinary retention contributed to but did not account for this reduction. Plasma levels of immunoreactive arginine vasopressin (ir-AVP) were reduced in both normal and dehydrated Long Evans rats after doses greater than 1 microgram kg-1 M320 s.c. In vitro, M320 caused persistent inhibition of twitches of the electrically stimulated rabbit vas deferens (IC50 1.7 nM). 8 These data suggest that M320 has potent opioid agonist activity at K-receptors and at higher concentrations stimulates mu- receptors. In the rat, its activity on K-receptors is associated with diuresis and suppression of plasma vasopressin levels. The antidiuresis seen after high doses may be due to its activity on mu-receptors, possibly at a central site.
Hilliard L, Mirabito Colafella K, Bulmer L, Puelles V, Singh R, Ow C Sci Rep. 2016; 6:33855.
PMID: 27653548 PMC: 5032121. DOI: 10.1038/srep33855.
Actions of tramadol on micturition in awake, freely moving rats.
Pandita R, Pehrson R, Christoph T, Friderichs E, Andersson K Br J Pharmacol. 2003; 139(4):741-8.
PMID: 12812997 PMC: 1573893. DOI: 10.1038/sj.bjp.0705297.
Evans R, Rice G, Olley J Br J Pharmacol. 1988; 95(3):777-82.
PMID: 3207993 PMC: 1854236. DOI: 10.1111/j.1476-5381.1988.tb11704.x.